|
|
Profile
|
Delegates :
Ryuji Kanno |
|
Incorporated :
July 1 , 2003 |
Paid in Capital :
1220 Million yen As of Apr. 2014 |
Employees :
59 人 |
Address :
246-2 Mizukami, Kakuganji, Tsuruoka YAMAGATA
〒9970052
|
TEL/FAX :
+81 3 3551 2180 / +81 3 3551 2181 |
URL：
http://humanmetabolome.com/ |
Attachment :
 HMT''s_Metabolomics.pdf [ 3MiB ] |
Mission/Background :
Human Metabolome Technologies (HMT) is a Japan-based biotechnology company developing capillary electrophoresis mass spectrometry (CE-MS) based metabolomics technologies and solutions to drive drug discovery, diagnosis, and food production. Our research and development methodology are at the heart of an emerging field of metabolomics and systems biology. |
|
Technology & Business
|
Metabolomics is a promising useful approach for the discovery of new disease biomarkers or the investigation of processes. The ultimate goal of metabolomics is to achieve a complete understanding of metabolome dynamics in combination with genomics, transcriptomics, and proteomics. The availability of all biological data will provide fundamental clues for medicine, pharmaceutical sciences, fermentation technology, and basic biology. Thus, integration of independent fields of research is essential for the achievement of a large-scale biological analysis.
|
|
Products & Service
|
Products & Service Name
|
Stage
|
Outline
|
Milestone
|
C-SCOPE
|
Service/Marketing
|
Absolute quantitative analysis of energy metabolism in tissues and cells
|
N/A
|
Advanced Scan
|
Service/Marketing
|
Advanced Scan proposes novel biomarker metabolites based on our unique analysis technology.
|
N/A
|
BASIC SCAN
|
Service/Marketing
|
BASIC SCAN provides global profiling by CE-TOFMS which targets about 900 ionic metabolites in a variety of biological samples.
|
N/A
|
DUAL SCAN
|
Service/Marketing
|
DUAL SCAN covers 300 hydrophobic metabolites by LC-TOFMS as well as 900 BASIC SCAN targets.
|
|
F-SCOPE
|
Service/Marketing
|
With F-SCOPE, 13C-labeled metabolites can be tracked through the major pathways of energy metabolism.
|
|
|
Highlights
|
Recent Papers(excerpt)
・Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder.
・A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study.
・Upregulation of colonic luminal polyamines produced by intestinal microbiota delays senescence in mice
|
|
Hot news
|
The latest published-paper
Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder.
http://www.ncbi.nlm.nih.gov/pubmed/25589364
|
|
|